Prevalence of human papillomavirus (HPV) types targeted by current vaccines and non-vaccine types.
- Zizipho Z. A. Mbulawa (846656)
- Cari van Schalkwyk (174758)
- Nai-Chung Hu (4730034)
- Tracy L. Meiring (4730043)
- Shaun Barnabas (3682840)
- Smritee Dabee (4730040)
- Heather Jaspan (632934)
- Jean-Mari Kriek (4730046)
- Shameem Z. Jaumdally (4730037)
- Etienne Muller (4223353)
- Linda-Gail Bekker (60754)
- David A. Lewis (140277)
- Janan Dietrich (452217)
- Glenda Gray (64254)
- Jo-Ann S. Passmore (509669)
- Anna-Lise Williamson (50758)
Publication date
January 2018
DOIAbstract
<p>Bivalent types: one or both HPV types targeted by the Cervarix HPV vaccine (HPV16/18); Quadrivalent types: one or more HPV types targeted by the Gardasil HPV vaccine (HPV6/11/16/18); Nonavalent types: one or more HPV types targeted by the Gardasil-9 HPV vaccine (HPV6/11/16/18/31/33/45/52/58); HR-HPV excluding vaccine & cross protective types (HPV-35/39/56/59).</p
Add to ORKG